The clinical utility of epoetin in cancer patients: a matter of perspective.
Barosi
G
G
Marchetti
M
M
D000740:Anemia / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects; D003362:Cost-Benefit Analysis; D017707:Erythrocyte Transfusion / Q000191:economics / Q000592:standards; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000191:economics / Q000628:therapy; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin